Vancomycin-resistant Staphylococcus aureus--New York, 2004

MMWR Morb Mortal Wkly Rep. 2004 Apr 23;53(15):322-3.


Staphylococcus aureus is a common cause of hospital- and community-acquired infections. The development of vancomycin-resistant enterococci in 1988 led the way to the emergence of vancomycin-resistant S. aureus (VRSA) (minimum inhibitory concentration [MIC] > or =32 microg/mL [3]), first recognized in 2002. This report describes the third documented clinical isolate of VRSA from a patient in the United States and provides evidence of failure to detect this VRSA by commonly used automated antimicrobial susceptibility testing.

MeSH terms

  • Cross Infection / prevention & control
  • Humans
  • Infection Control
  • Microbial Sensitivity Tests
  • New York / epidemiology
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology*
  • Staphylococcal Infections / prevention & control
  • Staphylococcus aureus* / drug effects
  • Staphylococcus aureus* / isolation & purification
  • Vancomycin Resistance*